Teva Pharmaceutical Industries is competing with major players Bayer, Biogen, and Novartis in the aflibercept biosimilar market.
1 report, 1 independent
Updated Jun 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Teva Pharmaceutical Industries is competing with major players Bayer, Biogen, and Novartis in the aflibercept biosimilar market.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Teva Pharmaceutical Industries Ltd. gained exclusive global rights to commercialize a biosimilar.Sub-event
Teva faces competition from Bayer, Biogen, and Novartis in the aflibercept biosimilar market.1 source
Keep exploring
The entities involved
-
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
-
BAYER
company in Prague, Czechia
-
Biogen
American multinational biotechnology company
-
Novartis
Swiss-American multinational pharmaceutical corporation